• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by Assure Holdings Corp.

    11/15/24 7:19:43 PM ET
    $IONM
    Medical/Dental Instruments
    Health Care
    Get the next $IONM alert in real time by email
    NT 10-Q 1 tmb-20240930xnt10q.htm NT 10-Q

    ​

    ​

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    ​

    FORM 12b-25

    NOTIFICATION OF LATE FILING

    ​

    (Check One)  

     

    ☐  Form 10-K     ☐  Form 20-F     ☐  Form 11-K     ☒    Form 10-Q

    ☐  Form 10-D     ☐  Form N-SAR     ☐  Form N-CSR

     

     

     

     

    For Period Ended: September 30, 2024

     

     

     

     

    ☐  Transition Report on Form 10-K

     

     

    ☐  Transition Report on Form 20-F

     

     

    ☐  Transition Report on Form 11-K

     

     

    ☐  Transition Report on Form 10-Q

     

     

    ☐  Transition Report on Form N-SAR

     

     

     

     

    For the Transition Period Ended:

    ​

    Read Instruction (on back page) Before Preparing Form. Please Print or Type.

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

    ​

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

    ​

    PART I — REGISTRANT INFORMATION

    ​

    Assure Holdings Corp.

    (Full Name of Registrant)

    ​

    (Former Name if Applicable)

    ​

    7887 East Belleview Avenue, Suite 1100

    (Address of Principal Executive Office (Street and Number)

    ​

    Denver, CO 80111

    (City, State and Zip Code)

    ​

    ​

    ​


    PART II — RULES 12b-25(b) AND (c)

    ​

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

    ​

    ☐   

     

    (a)

     

    The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

     

     

    (b)

     

    The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

     

     

    (c)

     

    The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

    ​


    ​

    PART III — NARRATIVE

    ​

    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

    ​

    Assure Holdings Corp. (the “Company”) is unable to file, without unreasonable effort and expense related to technical accounting associated with the tender offer to reprice convertible notes and amendment of contractual terms with Centurion Financial Trust related to outstanding secured debt, its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the “Form 10- Q”). The Company requires additional time to finalize its financial statements to be filed as part of the Form 10-Q.

    ​

    (Attach Extra Sheets if Needed)

    ​


    ​

    PART IV — OTHER INFORMATION

    ​

    ​

    (1)

    Name and telephone number of person to contact in regard to this notification

    ​

    John Farlinger

     

    720

     

    287-3093

    (Name)

     

    (Area Code)

     

    (Telephone Number)

    ​

    ​

    (2)

    Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).    ☒  Yes    ☐  No

     

     

    (3)

    Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?    ☒  Yes    ☐  No

    ​

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

    ​

    As discussed above in Part III, the Company is in the process of completing the preparation of its financial statements for its quarter ended September 30, 2024. The Company expects to report revenue of approximately nil for the quarter ended June 30, 2024, compared to revenue of approximately $48 thousand previously reported for the quarter ended September 30, 2023. The differences in revenue is primarily attributable to the following factors: The Company exploring strategic alternatives for its clinical operations and reporting revenue related to the clinical operations as a component of discontinued operations.


    ​


    ​

    ​

    Assure Holdings Corp.

    (Name of Registrant as Specified in Charter)

    ​

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

    ​

    Date

     

    November 15, 2024

     

    By

     

    /s/ John Farlinger

     

     

     

     

     

     

    John Farlinger

     

     

     

     

     

     

    President and Chief Executive Officer

    ​

    INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

    ​

    ​

    ​

    ATTENTION

    Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

    ​


    Get the next $IONM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IONM

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $IONM
    Financials

    Live finance-specific insights

    See more
    • Assure & Danam Reschedule Corporate Update Call & Webcast

      DENVER, May 17, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced today that management has rescheduled the joint corporate update call with Danam for Wednesday, May 22, 2024 at 4:00 PM Eastern Time. Conference Call InformationDate: Wednesday, May 22, 2024Time: 4:00 PM Eastern TimeToll Free: 1-877-545-0523International: 1-973-528-0016Participant Access Code: 229289Webcast Link: https://www.webcaster4.com/Webcast/Page/2566/50637 Conference Call Replay InformationToll Free:   1-877-481-4010International: 1-919-882-2331Replay Passcode: 50637Webcast Replay: h

      5/17/24 2:04:20 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • Assure & Danam Postpone Corporate Update Call & Webcast Scheduled for May 16

      DENVER, May 15, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced today that the joint corporate update call with Danam scheduled for Thursday, May 16, 2024 at 4 p.m. Eastern Time has been postponed. The Company plans to reschedule the conference call at a later date. About Assure Holdings Assure Holdings Corp. is a best-in-class provider of outsourced intraoperative neuromonitoring and remote neurology services. The Company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive proc

      5/15/24 8:50:44 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • Assure & Danam to Host Corporate Update Call & Webcast

      DENVER, May 13, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced today that management will host a joint corporate update call with Danam on Thursday, May 16, 2024 at 4:00 PM Eastern Time to provide a corporate update. Conference Call InformationDate: Thursday, May 16, 2024Time: 4:00 PM Eastern TimeToll Free: 877-545-0523International: 973-528-0016Participant Access Code: 229289Webcast Link: https://www.webcaster4.com/Webcast/Page/2566/50637 Conference Call Replay InformationToll Free: 877-481-4010International: 919-882-2331Replay Passcode: 50637Webc

      5/13/24 4:01:00 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care

    $IONM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Assure Announces Amendment of Exchange Offer Relating to its Convertible Notes

      Assure Holdings Corp. ("Assure" or the "Company") (OTC:IONM), today announced that it has amended the Convertible Note Exchange Offer of June 21, 2024, relating to the Company's 9% Convertible Debentures due in 2023 and 2024 (the "Assure Convertible Debentures"). This ninth amendment further amends and restates certain sections of the Convertible Note Exchange Offer ("Amended Offer Letter") as follows: (i) updates the Amended Offer Letter to reflect a change in the consideration being offered for each $1,000 claim from 238.44 shares of common stock consisting of principal amount, and accrued and unpaid interest through, and including, July 19, 2024 to 1,000 shares of common stock consisting

      9/6/24 8:45:00 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • Assure Announces Further Extension of Exchange Offer Relating to its Convertible Notes

      DENVER, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. ("Assure" or the "Company") (OTC:IONM), today announced that it has extended the expiration date of its exchange offer (the "Offer") relating to the Company's 9% Convertible Debentures due 2023 and 2024 (the "Assure Convertible Debentures"). As a result of the extension, the Exchange Offer is now scheduled to expire at 11:59 p.m. (Denver Time), on September 6, 2024 (the "Expiration Date") unless further extended. The Offer was originally scheduled to expire at 11:59 p.m. (Denver Time) on July 19, 2024, and has been extended several times to now expire at 11:59 p.m. (Denver Time), on September 6, 2024. Except for the extension

      8/26/24 8:00:00 AM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • Assure Announces Further Extension of Exchange Offer Relating to its Convertible Notes

      DENVER, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. ("Assure" or the "Company") (OTC:IONM), today announced that it has extended the expiration date of its exchange offer (the "Offer") relating to the Company's 9% Convertible Debentures due 2023 and 2024 (the "Assure Convertible Debentures"). As a result of the extension, the Exchange Offer is now scheduled to expire at 11:59 p.m. (Denver Time), on August 23, 2024 (the "Expiration Date") unless further extended. The Offer was originally scheduled to expire at 11:59 p.m. (Denver Time) on July 19, 2024, and has been extended several times to now expire at 11:59 p.m. (Denver Time), on August 23, 2024. Except for the extension of

      8/19/24 8:00:00 AM ET
      $IONM
      Medical/Dental Instruments
      Health Care

    $IONM
    SEC Filings

    See more
    • Assure Holdings Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Assure Holdings Corp. (0001798270) (Filer)

      1/22/25 4:00:28 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • Assure Holdings Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - Assure Holdings Corp. (0001798270) (Filer)

      12/23/24 4:01:32 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • SEC Form NT 10-Q filed by Assure Holdings Corp.

      NT 10-Q - Assure Holdings Corp. (0001798270) (Filer)

      11/15/24 7:19:43 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care

    $IONM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $IONM
    Leadership Updates

    Live Leadership Updates

    See more

    $IONM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form SC 13G/A filed by Assure Holdings Corp. (Amendment)

      SC 13G/A - Assure Holdings Corp. (0001798270) (Subject)

      2/9/24 10:14:47 AM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Assure Holdings Corp. (Amendment)

      SC 13G/A - Assure Holdings Corp. (0001798270) (Subject)

      2/10/23 3:08:00 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Assure Holdings Corp. (Amendment)

      SC 13G/A - Assure Holdings Corp. (0001798270) (Subject)

      1/10/23 4:45:27 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • Assure Holdings Announces Results of Annual General Meeting of Shareholders

      DENVER, Dec. 30, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced today that it held its annual general meeting of shareholders on December 28, 2022 (the "Meeting") and that all matters submitted to the shareholders of the Company for approval as set out in the Company's definitive proxy statement dated December 2, 2022 (the "Proxy Statement"), were approved by the requisite majority of votes cast at the Meeting, including: Electing the following nominees to the board of directors of the Company to serve until the Company's next annual general meeting of

      12/30/22 4:02:00 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • Assure Holdings Further Strengthens Business Development Team with Hiring of Robynn Sweet as Vice President, Strategic Accounts

      DENVER, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced the appointment of Robynn Sweet to the position of vice president, strategic accounts. Prior to joining Assure, Ms. Sweet worked at Premier, Inc. serving as director of Group Purchasing Organization ("GPO") sales for national accounts. Before that, Ms. Sweet was regional vice president of sales at HealthTrust where her efforts were instrumental in driving more than $100 million in corporate revenue. Ms. Sweet earned a Bachelor of Science in Nursing from the University of Texas Health Scienc

      8/23/22 4:30:00 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • Assure Holdings Further Strengthens Clinical Team with Hiring of James Watt as National Technologist Director

      DENVER, April 26, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced the appointment of James Watt to the position of national technologist director. Mr. Watt reports to Assure's vice president of clinical operations, Stephanie Krouse. In his new role, Mr. Watt leads day-to-day operations for Assure's clinical technologist team, ensuring quality of service and overseeing the Company's training and development program. In addition, Mr. Watt will play an important role in the establishment of new competencies that will drive Assure's expansion into adjacent m

      4/26/22 8:30:00 AM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Parsons Preston T

      4 - Assure Holdings Corp. (0001798270) (Issuer)

      4/13/23 8:43:47 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Burian Martin Andrew

      4 - Assure Holdings Corp. (0001798270) (Issuer)

      4/10/23 7:31:27 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Parsons Preston T

      4 - Assure Holdings Corp. (0001798270) (Issuer)

      4/10/23 4:41:09 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care